Thyroid Gland Disorders – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Thyroid Gland Disorders – Drugs In Development, 2024 report and make more profitable business decisions.
Thyroid gland disorders are conditions that affect the function of the thyroid, a butterfly-shaped gland in the front of the neck. The thyroid produces hormones that regulate metabolism, growth, development and body temperature. Some of the common thyroid disorders are hypothyroidism, goiter, hyperthyroidism, and thyroid cancer. Thyroid disorders can be diagnosed by blood tests that measure the levels of thyroid hormones and thyroid-stimulating hormone (TSH). Treatment depends on the type and severity of the disorder and may include medication, surgery, radioactive iodine, or hormone replacement therapy.
The Thyroid Gland Disorders drugs in development market research report provide comprehensive information on the therapeutics under development for Thyroid Gland Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Thyroid Gland Disorders and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Thyroid Gland Disorders | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 28 molecules, with 28 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Thyroid Gland Disorders therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Thyroid Gland Disorders pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Thyroid Gland Disorders treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AbbVie IncadvanceCor GmbH
Alpha Cancer Technologies Inc
AV7 Ltd
Conduit Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Diurnal Group Plc
ellennbe GmbH
GSK plc
HanAll Biopharma Co Ltd
iCELL Biotechnology Co Ltd
Immunovant Inc
Kashiv BioSciences LLC
Lan-yi Therapeutics Ltd
Medosome Biotec LLC
MyMD Pharmaceuticals Inc
Omeros Corp
OSE Immunotherapeutics SA
Prolevi Bio AB
Protheragen Inc
Sention Therapeutics LLC
Septerna Inc
Spectrix Therapeutics LLC
Synthonics Inc
Tourmaline Sub Inc
Virtici LLC
Worg Pharmaceuticals Hangzhou Co Ltd
Xeris Biopharma Holdings Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Thyroid Gland Disorders reports